Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

by Shuhang Wang, Shundong Cang, Delong Liu
Published 2016-04-01

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

by Zhenshu Xu, Shundong Cang, Ting Yang, Delong Liu
Published 2009-03-01

Immune-associated molecular occurrence and prognosis predictor of hepatocellular carcinoma: an integrated analysis of GEO datasets

by Guanjun Liu, Dongmei Wu, Yiyang Wen, Shundong Cang
Published 2021-01-01

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis

by Junya Yan, Xiaowen Wu, Jiayi Yu, Yanyan Zhu, Shundong Cang
Published 2020-11-01

Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells

by Shundong Cang, Xiaobin Xu, Yuehua Ma, Delong Liu, J. W. Chiao
Published 2016-01-01

Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation

by Jingjing Wu, Shundong Cang, Christina Liu, Whitman Ochiai, Jen Wei Chiao
Published 2020-06-01

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data

by Yanyan Zhu, Shundong Cang, Bowang Chen, Bowang Chen, Yue Gu, Yue Gu, Yue Gu, Miaomiao Jiang, Miaomiao Jiang, Junya Yan, Fengmin Shao, Fengmin Shao, Fengmin Shao, Xiaoyun Huang, Xiaoyun Huang
Published 2020-12-01